A Prospective, Randomized Trial of Enoxaparin and Unfractionated Heparin in Patients With Acute Coronary Syndromes - Results in Patients Undergoing Percutaneous Coronary Intervention - SYNERGY-PCI


The goal of this substudy of patients undergoing PCI in the SYNERGY trial was to evaluate the safety and efficacy of enoxaparin compared with unfractionated heparin (UFH) in high-risk patients with non-ST-segment elevation acute coronary syndromes (ACSs).